Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | -3.31% |
|
-10.69% | +40.96% |
Business Summary
Number of employees: 14
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Lewis
CEO | Chief Executive Officer | 54 | 30/11/17 |
Jack Callicutt
DFI | Director of Finance/CFO | 56 | 30/06/13 |
Ezra R. lowe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Pol Boudes
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/03/20 |
Harold Shlevin
BRD | Director/Board Member | 75 | 30/09/12 |
Susan Thornton
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Freeman
BRD | Director/Board Member | 62 | 30/04/11 |
Benjamin Carson
BRD | Director/Board Member | 73 | 12-06 |
Gil Omenn
BRD | Director/Board Member | 83 | 22/09/14 |
Gilbert Amelio
BRD | Director/Board Member | 81 | 11/02/09 |
Harold Shlevin
BRD | Director/Board Member | 75 | 30/09/12 |
Dick Uihlein
CHM | Chairman | 79 | 13/12/17 |
Marc Rubin
BRD | Director/Board Member | 69 | 11/10/11 |
Kary Eldred
BRD | Director/Board Member | 50 | 31/12/17 |
Richard Zordani
BRD | Director/Board Member | 52 | 31/08/20 |
Elissa Schwartz
BRD | Director/Board Member | 54 | 31/08/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,235,000 | 0 | 0 | 67.65 % |
Stock B | 1 | 62,148,134 | 42,881,405 ( 69.00 %) | 0 | |
Stock C | 0 | 176 | 0 | 0 |
Company contact information
Galectin Therapeutics, Inc.
4960 Peachtree Industrial Boulevard Suite 240
30071, Norcross
+(678) 620-3186
http://www.galectintherapeutics.com![address Galectin Therapeutics Inc.(GALT)](https://cdn.zonebourse.com/static/address/10274771.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.96% | 145M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
-12.11% | 26.22B | |
+12.62% | 26.36B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- GALT Stock
- Company Galectin Therapeutics Inc.